iTeos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	379	392	695	1,642	1,185
Market Cap Growth	-	-43.60%	-57.70%	38.57%	-
Enterprise Value	-148	-134	86	799	849
PE Ratio	-3.48	-3.48	7.19	7.66	-27.31
PS Ratio	30.05	31.11	2.60	4.76	-
PB Ratio	0.66	0.68	1.05	2.97	3.67
P/FCF Ratio	-3.67	-3.67	-6.20	3.21	-46.42
P/OCF Ratio	-3.78	-3.78	-6.25	3.20	-47.08
EV/Sales Ratio	-10.66	-10.66	0.32	2.32	-
EV/EBITDA Ratio	1.24	1.24	0.58	3.11	-22.60
EV/EBIT Ratio	1.23	1.23	0.58	3.11	-22.28
EV/FCF Ratio	1.26	1.26	-0.77	1.56	-33.24
Debt / Equity Ratio	0.01	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-0.06	-0.06	0.03	0.02	-
Debt / FCF Ratio	-0.06	-0.06	-0.04	0.01	-
Quick Ratio	13.30	13.30	14.63	2.80	22.44
Current Ratio	13.76	13.76	14.96	2.88	22.64
Asset Turnover	0.02	0.02	0.34	0.56	0
Return on Equity (ROE)	-18.40%	-18.40%	15.10%	56.20%	-30.30%
Return on Assets (ROA)	-16.20%	-16.20%	12.10%	34.90%	-17.50%
Return on Capital (ROIC)	-25.99%	-25.99%	12.29%	36.70%	-14.00%
Earnings Yield	-29.76%	-28.75%	13.91%	13.06%	-3.66%
FCF Yield	-28.20%	-27.24%	-16.14%	31.17%	-2.15%
Buyback Yield / Dilution	5.30%	5.30%	0.02%	-150.49%	-7336.29%
Total Shareholder Return	5.30%	5.30%	0.02%	-150.49%	-7336.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).